Obesity among those with mental disorders: a National Institute of Mental Health meeting report.
about
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainPragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomesComanagement of Pediatric Depression and Obesity: A Clear Need for EvidenceDo premenopausal women with major depression have low bone mineral density? A 36-month prospective studyDietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.A behavioral weight-loss intervention in persons with serious mental illnessPavlovian conditioning and cross-sensitization studies raise challenges to the hypothesis that overeating is an addictive behavior.Comparing Adult Males and Females in the United States to Examine the Association between Body Mass Index and Frequent Mental Distress: An Analysis of Data from BRFSS 2011.Health Promotion for Young Adults With Serious Mental Illness.Metabolic Effects of Antidepressant TreatmentAssociation of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia.Institutional policy changes aimed at addressing obesity among mental health clients.Medication adherence among older adults with schizophrenia.The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature reviewUnraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.Mood, food, and obesity.Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care.Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophreniaHealth promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials.Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trialMortality and guideline-concordant care for older patients with schizophrenia: a retrospective longitudinal studyA study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics.Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study.Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention settingPhysical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Almost all antipsychotics result in weight gain: a meta-analysis.Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors.Attitudes and beliefs associated with leisure-time physical activity among African American adults.Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit.The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial.STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications.Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence.Pharmacogenetics of antipsychotic-induced side effectsAssociation of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study).Delivering a lifestyle and weight loss intervention to individuals in real-world mental health settings: Lessons and opportunitiesA 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.
P2860
Q21561008-8F86F9E4-B965-4C70-800A-ECEF346F978BQ24288983-6475BE93-EDA5-47B4-96CC-75B79D80C79FQ28083785-59DA2F00-46B0-4AC8-A011-359C20EC0EE1Q28728705-99B5271F-EC8B-4701-B17A-771D4EA0E2AFQ30372082-44E88082-77C1-4ACD-8125-577F89A9B874Q30542864-94485C8A-9F10-4ED0-ACEE-5886B18D82BDQ30577612-FA44BCF7-3081-4659-9881-64FED111C5A2Q30718006-0AB16374-A6E6-459D-8289-9B932EDDD1B0Q33657319-61D1DBD1-1A0E-4B1B-9C35-607CEC4EB542Q33712365-6DEDCB7C-ECEB-4FAD-A884-418F7176FA05Q33717601-45172C49-1464-45AE-A89F-1D0FD3BF166BQ33891235-381D12BF-6361-407B-B6D5-E59192B9E506Q33893240-68CB1EC8-5363-4E80-9D5A-19162290D75EQ33924804-2596AA71-07B0-4A18-BDAD-D1D4D41C4F5EQ34000520-ECCB5943-D422-4E6D-84B0-33B27ABD34E0Q34113945-63571CA9-DF53-4D36-B4A5-50DCDA199DC8Q34116503-12BCB018-9558-4ECE-837D-0854BFF73695Q34214660-5516BD4A-956D-42EB-BCCE-DEF6CE7DEAACQ34248044-032DCA1B-87F0-4C33-9CEC-8520FCF7F50AQ34254308-B5BA6EB1-B657-40EF-BBAB-3DD15C77DE67Q34334535-B95CA41E-7B85-41EB-ABED-7691FF722B42Q34468141-F4A5723F-E265-4CA4-B315-A4C5DE4159EDQ34488385-871D6349-1563-42D0-BEB2-CF0AF77B1839Q34507173-B14B2BCB-59F1-4000-AE07-292ADE92E7F5Q34564181-7F1E6C82-94DD-4927-882B-B4FF5041B520Q34619959-9DCF3DA4-0BAB-446C-BF6B-FA6F08E55D95Q34623350-14B3BA13-3EF0-4A78-8496-F8438E8C64FFQ34661499-D405E2A4-15D0-498E-AFC6-C9D0DCD55D69Q34722921-1D50CF72-FFEF-4867-A504-B4AFBA53D300Q34783782-934B2FF5-3C55-4A08-8E95-13F3E2FF2A09Q34786258-BFAF1E78-D734-4A09-BD6B-DAC64A765852Q34807210-DFD1E1ED-8FC1-4301-BCC4-67706B4686EAQ35001376-E74FEE53-DA7A-483A-B115-08BF256DA8B7Q35016170-57199026-3FE8-450E-B12E-C44B75321E25Q35222921-325348DA-F3DE-464B-BB4E-0B232CDC9156Q35237129-60BFDF49-1753-42E2-ADB3-B758BA182EDFQ35460642-822B7498-639D-4188-8102-F78F364CA13FQ35646310-1030A22E-3EBC-4015-A8BD-D2D25EB64228Q35833294-F29E2034-F2F8-4337-A35E-1B6567CC0E34Q35911508-FC0D37CF-C2D0-4F1E-B1EC-4770AA054A62
P2860
Obesity among those with mental disorders: a National Institute of Mental Health meeting report.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Obesity among those with menta ...... Mental Health meeting report.
@en
Obesity among those with menta ...... Mental Health meeting report.
@nl
type
label
Obesity among those with menta ...... Mental Health meeting report.
@en
Obesity among those with menta ...... Mental Health meeting report.
@nl
prefLabel
Obesity among those with menta ...... Mental Health meeting report.
@en
Obesity among those with menta ...... Mental Health meeting report.
@nl
P2093
P1476
Obesity among those with menta ...... Mental Health meeting report.
@en
P2093
Andrea L Dunn
Anthony N Fabricatore
Betty Vreeland
Gail L Daumit
James A Blumenthal
John W Newcomer
Joseph R Hibbeln
Mark B Cope
William T Riley
P304
P356
10.1016/J.AMEPRE.2008.11.020
P577
2009-04-01T00:00:00Z